Global Artemisinin Derivatives Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Artemisinin Derivatives market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Artemisinin Derivatives is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Artemisinin Derivatives is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Artemisinin Derivatives is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Artemisinin Derivatives players cover Sanofi, KPC Pharmaceuticals, Guangxi Xiancaotang Pharmaceutical, Guilin Pharmaceutical, Kerui Nanhai Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Artemisinin Derivatives Industry Forecast” looks at past sales and reviews total world Artemisinin Derivatives sales in 2024, providing a comprehensive analysis by region and market sector of projected Artemisinin Derivatives sales for 2025 through 2031. With Artemisinin Derivatives sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artemisinin Derivatives industry.
This Insight Report provides a comprehensive analysis of the global Artemisinin Derivatives landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artemisinin Derivatives portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Artemisinin Derivatives market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artemisinin Derivatives and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artemisinin Derivatives.
This report presents a comprehensive overview, market shares, and growth opportunities of Artemisinin Derivatives market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Artemisinin Derivatives market?
What factors are driving Artemisinin Derivatives market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Artemisinin Derivatives market opportunities vary by end market size?
How does Artemisinin Derivatives break out by Type, by Application?
The global Artemisinin Derivatives market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Artemisinin Derivatives is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Artemisinin Derivatives is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Artemisinin Derivatives is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Artemisinin Derivatives players cover Sanofi, KPC Pharmaceuticals, Guangxi Xiancaotang Pharmaceutical, Guilin Pharmaceutical, Kerui Nanhai Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Artemisinin Derivatives Industry Forecast” looks at past sales and reviews total world Artemisinin Derivatives sales in 2024, providing a comprehensive analysis by region and market sector of projected Artemisinin Derivatives sales for 2025 through 2031. With Artemisinin Derivatives sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artemisinin Derivatives industry.
This Insight Report provides a comprehensive analysis of the global Artemisinin Derivatives landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artemisinin Derivatives portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Artemisinin Derivatives market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artemisinin Derivatives and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artemisinin Derivatives.
This report presents a comprehensive overview, market shares, and growth opportunities of Artemisinin Derivatives market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Dihydroartemisinin
- Artemisunate
- Others
- Malaria Treatment
- Scientific Research
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi
- KPC Pharmaceuticals
- Guangxi Xiancaotang Pharmaceutical
- Guilin Pharmaceutical
- Kerui Nanhai Pharmaceutical
- Shanghai Natural Bio-engineering Co
- Novanat Bioresource
- Botanical Extracts EPZ Ltd
What is the 10-year outlook for the global Artemisinin Derivatives market?
What factors are driving Artemisinin Derivatives market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Artemisinin Derivatives market opportunities vary by end market size?
How does Artemisinin Derivatives break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Artemisinin Derivatives Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Artemisinin Derivatives by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Artemisinin Derivatives by Country/Region, 2020, 2024 & 2031
2.2 Artemisinin Derivatives Segment by Type
2.2.1 Dihydroartemisinin
2.2.2 Artemisunate
2.2.3 Others
2.3 Artemisinin Derivatives Sales by Type
2.3.1 Global Artemisinin Derivatives Sales Market Share by Type (2020-2025)
2.3.2 Global Artemisinin Derivatives Revenue and Market Share by Type (2020-2025)
2.3.3 Global Artemisinin Derivatives Sale Price by Type (2020-2025)
2.4 Artemisinin Derivatives Segment by Application
2.4.1 Malaria Treatment
2.4.2 Scientific Research
2.4.3 Others
2.5 Artemisinin Derivatives Sales by Application
2.5.1 Global Artemisinin Derivatives Sale Market Share by Application (2020-2025)
2.5.2 Global Artemisinin Derivatives Revenue and Market Share by Application (2020-2025)
2.5.3 Global Artemisinin Derivatives Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Artemisinin Derivatives Breakdown Data by Company
3.1.1 Global Artemisinin Derivatives Annual Sales by Company (2020-2025)
3.1.2 Global Artemisinin Derivatives Sales Market Share by Company (2020-2025)
3.2 Global Artemisinin Derivatives Annual Revenue by Company (2020-2025)
3.2.1 Global Artemisinin Derivatives Revenue by Company (2020-2025)
3.2.2 Global Artemisinin Derivatives Revenue Market Share by Company (2020-2025)
3.3 Global Artemisinin Derivatives Sale Price by Company
3.4 Key Manufacturers Artemisinin Derivatives Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Artemisinin Derivatives Product Location Distribution
3.4.2 Players Artemisinin Derivatives Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ARTEMISININ DERIVATIVES BY GEOGRAPHIC REGION
4.1 World Historic Artemisinin Derivatives Market Size by Geographic Region (2020-2025)
4.1.1 Global Artemisinin Derivatives Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Artemisinin Derivatives Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Artemisinin Derivatives Market Size by Country/Region (2020-2025)
4.2.1 Global Artemisinin Derivatives Annual Sales by Country/Region (2020-2025)
4.2.2 Global Artemisinin Derivatives Annual Revenue by Country/Region (2020-2025)
4.3 Americas Artemisinin Derivatives Sales Growth
4.4 APAC Artemisinin Derivatives Sales Growth
4.5 Europe Artemisinin Derivatives Sales Growth
4.6 Middle East & Africa Artemisinin Derivatives Sales Growth
5 AMERICAS
5.1 Americas Artemisinin Derivatives Sales by Country
5.1.1 Americas Artemisinin Derivatives Sales by Country (2020-2025)
5.1.2 Americas Artemisinin Derivatives Revenue by Country (2020-2025)
5.2 Americas Artemisinin Derivatives Sales by Type (2020-2025)
5.3 Americas Artemisinin Derivatives Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artemisinin Derivatives Sales by Region
6.1.1 APAC Artemisinin Derivatives Sales by Region (2020-2025)
6.1.2 APAC Artemisinin Derivatives Revenue by Region (2020-2025)
6.2 APAC Artemisinin Derivatives Sales by Type (2020-2025)
6.3 APAC Artemisinin Derivatives Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Artemisinin Derivatives by Country
7.1.1 Europe Artemisinin Derivatives Sales by Country (2020-2025)
7.1.2 Europe Artemisinin Derivatives Revenue by Country (2020-2025)
7.2 Europe Artemisinin Derivatives Sales by Type (2020-2025)
7.3 Europe Artemisinin Derivatives Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Artemisinin Derivatives by Country
8.1.1 Middle East & Africa Artemisinin Derivatives Sales by Country (2020-2025)
8.1.2 Middle East & Africa Artemisinin Derivatives Revenue by Country (2020-2025)
8.2 Middle East & Africa Artemisinin Derivatives Sales by Type (2020-2025)
8.3 Middle East & Africa Artemisinin Derivatives Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Artemisinin Derivatives
10.3 Manufacturing Process Analysis of Artemisinin Derivatives
10.4 Industry Chain Structure of Artemisinin Derivatives
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Artemisinin Derivatives Distributors
11.3 Artemisinin Derivatives Customer
12 WORLD FORECAST REVIEW FOR ARTEMISININ DERIVATIVES BY GEOGRAPHIC REGION
12.1 Global Artemisinin Derivatives Market Size Forecast by Region
12.1.1 Global Artemisinin Derivatives Forecast by Region (2026-2031)
12.1.2 Global Artemisinin Derivatives Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Artemisinin Derivatives Forecast by Type (2026-2031)
12.7 Global Artemisinin Derivatives Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Artemisinin Derivatives Product Portfolios and Specifications
13.1.3 Sanofi Artemisinin Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 KPC Pharmaceuticals
13.2.1 KPC Pharmaceuticals Company Information
13.2.2 KPC Pharmaceuticals Artemisinin Derivatives Product Portfolios and Specifications
13.2.3 KPC Pharmaceuticals Artemisinin Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 KPC Pharmaceuticals Main Business Overview
13.2.5 KPC Pharmaceuticals Latest Developments
13.3 Guangxi Xiancaotang Pharmaceutical
13.3.1 Guangxi Xiancaotang Pharmaceutical Company Information
13.3.2 Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Product Portfolios and Specifications
13.3.3 Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Guangxi Xiancaotang Pharmaceutical Main Business Overview
13.3.5 Guangxi Xiancaotang Pharmaceutical Latest Developments
13.4 Guilin Pharmaceutical
13.4.1 Guilin Pharmaceutical Company Information
13.4.2 Guilin Pharmaceutical Artemisinin Derivatives Product Portfolios and Specifications
13.4.3 Guilin Pharmaceutical Artemisinin Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Guilin Pharmaceutical Main Business Overview
13.4.5 Guilin Pharmaceutical Latest Developments
13.5 Kerui Nanhai Pharmaceutical
13.5.1 Kerui Nanhai Pharmaceutical Company Information
13.5.2 Kerui Nanhai Pharmaceutical Artemisinin Derivatives Product Portfolios and Specifications
13.5.3 Kerui Nanhai Pharmaceutical Artemisinin Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Kerui Nanhai Pharmaceutical Main Business Overview
13.5.5 Kerui Nanhai Pharmaceutical Latest Developments
13.6 Shanghai Natural Bio-engineering Co
13.6.1 Shanghai Natural Bio-engineering Co Company Information
13.6.2 Shanghai Natural Bio-engineering Co Artemisinin Derivatives Product Portfolios and Specifications
13.6.3 Shanghai Natural Bio-engineering Co Artemisinin Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Shanghai Natural Bio-engineering Co Main Business Overview
13.6.5 Shanghai Natural Bio-engineering Co Latest Developments
13.7 Novanat Bioresource
13.7.1 Novanat Bioresource Company Information
13.7.2 Novanat Bioresource Artemisinin Derivatives Product Portfolios and Specifications
13.7.3 Novanat Bioresource Artemisinin Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Novanat Bioresource Main Business Overview
13.7.5 Novanat Bioresource Latest Developments
13.8 Botanical Extracts EPZ Ltd
13.8.1 Botanical Extracts EPZ Ltd Company Information
13.8.2 Botanical Extracts EPZ Ltd Artemisinin Derivatives Product Portfolios and Specifications
13.8.3 Botanical Extracts EPZ Ltd Artemisinin Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Botanical Extracts EPZ Ltd Main Business Overview
13.8.5 Botanical Extracts EPZ Ltd Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Artemisinin Derivatives Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Artemisinin Derivatives Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Dihydroartemisinin
Table 4. Major Players of Artemisunate
Table 5. Major Players of Others
Table 6. Global Artemisinin Derivatives Sales byType (2020-2025) & (MT)
Table 7. Global Artemisinin Derivatives Sales Market Share byType (2020-2025)
Table 8. Global Artemisinin Derivatives Revenue byType (2020-2025) & ($ million)
Table 9. Global Artemisinin Derivatives Revenue Market Share byType (2020-2025)
Table 10. Global Artemisinin Derivatives Sale Price byType (2020-2025) & (USD/MT)
Table 11. Global Artemisinin Derivatives Sale by Application (2020-2025) & (MT)
Table 12. Global Artemisinin Derivatives Sale Market Share by Application (2020-2025)
Table 13. Global Artemisinin Derivatives Revenue by Application (2020-2025) & ($ million)
Table 14. Global Artemisinin Derivatives Revenue Market Share by Application (2020-2025)
Table 15. Global Artemisinin Derivatives Sale Price by Application (2020-2025) & (USD/MT)
Table 16. Global Artemisinin Derivatives Sales by Company (2020-2025) & (MT)
Table 17. Global Artemisinin Derivatives Sales Market Share by Company (2020-2025)
Table 18. Global Artemisinin Derivatives Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Artemisinin Derivatives Revenue Market Share by Company (2020-2025)
Table 20. Global Artemisinin Derivatives Sale Price by Company (2020-2025) & (USD/MT)
Table 21. Key Manufacturers Artemisinin Derivatives Producing Area Distribution and Sales Area
Table 22. Players Artemisinin Derivatives Products Offered
Table 23. Artemisinin Derivatives Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Artemisinin Derivatives Sales by Geographic Region (2020-2025) & (MT)
Table 27. Global Artemisinin Derivatives Sales Market Share Geographic Region (2020-2025)
Table 28. Global Artemisinin Derivatives Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Artemisinin Derivatives Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Artemisinin Derivatives Sales by Country/Region (2020-2025) & (MT)
Table 31. Global Artemisinin Derivatives Sales Market Share by Country/Region (2020-2025)
Table 32. Global Artemisinin Derivatives Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Artemisinin Derivatives Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Artemisinin Derivatives Sales by Country (2020-2025) & (MT)
Table 35. Americas Artemisinin Derivatives Sales Market Share by Country (2020-2025)
Table 36. Americas Artemisinin Derivatives Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Artemisinin Derivatives Sales byType (2020-2025) & (MT)
Table 38. Americas Artemisinin Derivatives Sales by Application (2020-2025) & (MT)
Table 39. APAC Artemisinin Derivatives Sales by Region (2020-2025) & (MT)
Table 40. APAC Artemisinin Derivatives Sales Market Share by Region (2020-2025)
Table 41. APAC Artemisinin Derivatives Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Artemisinin Derivatives Sales byType (2020-2025) & (MT)
Table 43. APAC Artemisinin Derivatives Sales by Application (2020-2025) & (MT)
Table 44. Europe Artemisinin Derivatives Sales by Country (2020-2025) & (MT)
Table 45. Europe Artemisinin Derivatives Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Artemisinin Derivatives Sales byType (2020-2025) & (MT)
Table 47. Europe Artemisinin Derivatives Sales by Application (2020-2025) & (MT)
Table 48. Middle East & Africa Artemisinin Derivatives Sales by Country (2020-2025) & (MT)
Table 49. Middle East & Africa Artemisinin Derivatives Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Artemisinin Derivatives Sales byType (2020-2025) & (MT)
Table 51. Middle East & Africa Artemisinin Derivatives Sales by Application (2020-2025) & (MT)
Table 52. Key Market Drivers & Growth Opportunities of Artemisinin Derivatives
Table 53. Key Market Challenges & Risks of Artemisinin Derivatives
Table 54. Key IndustryTrends of Artemisinin Derivatives
Table 55. Artemisinin Derivatives Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Artemisinin Derivatives Distributors List
Table 58. Artemisinin Derivatives Customer List
Table 59. Global Artemisinin Derivatives SalesForecast by Region (2026-2031) & (MT)
Table 60. Global Artemisinin Derivatives RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Artemisinin Derivatives SalesForecast by Country (2026-2031) & (MT)
Table 62. Americas Artemisinin Derivatives Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Artemisinin Derivatives SalesForecast by Region (2026-2031) & (MT)
Table 64. APAC Artemisinin Derivatives Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Artemisinin Derivatives SalesForecast by Country (2026-2031) & (MT)
Table 66. Europe Artemisinin Derivatives RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Artemisinin Derivatives SalesForecast by Country (2026-2031) & (MT)
Table 68. Middle East & Africa Artemisinin Derivatives RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Artemisinin Derivatives SalesForecast byType (2026-2031) & (MT)
Table 70. Global Artemisinin Derivatives RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Artemisinin Derivatives SalesForecast by Application (2026-2031) & (MT)
Table 72. Global Artemisinin Derivatives RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Sanofi Basic Information, Artemisinin Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 74. Sanofi Artemisinin Derivatives Product Portfolios and Specifications
Table 75. Sanofi Artemisinin Derivatives Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 76. Sanofi Main Business
Table 77. Sanofi Latest Developments
Table 78. KPC Pharmaceuticals Basic Information, Artemisinin Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 79. KPC Pharmaceuticals Artemisinin Derivatives Product Portfolios and Specifications
Table 80. KPC Pharmaceuticals Artemisinin Derivatives Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 81. KPC Pharmaceuticals Main Business
Table 82. KPC Pharmaceuticals Latest Developments
Table 83. Guangxi Xiancaotang Pharmaceutical Basic Information, Artemisinin Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 84. Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Product Portfolios and Specifications
Table 85. Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Guangxi Xiancaotang Pharmaceutical Main Business
Table 87. Guangxi Xiancaotang Pharmaceutical Latest Developments
Table 88. Guilin Pharmaceutical Basic Information, Artemisinin Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 89. Guilin Pharmaceutical Artemisinin Derivatives Product Portfolios and Specifications
Table 90. Guilin Pharmaceutical Artemisinin Derivatives Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 91. Guilin Pharmaceutical Main Business
Table 92. Guilin Pharmaceutical Latest Developments
Table 93. Kerui Nanhai Pharmaceutical Basic Information, Artemisinin Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 94. Kerui Nanhai Pharmaceutical Artemisinin Derivatives Product Portfolios and Specifications
Table 95. Kerui Nanhai Pharmaceutical Artemisinin Derivatives Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 96. Kerui Nanhai Pharmaceutical Main Business
Table 97. Kerui Nanhai Pharmaceutical Latest Developments
Table 98. Shanghai Natural Bio-engineering Co Basic Information, Artemisinin Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 99. Shanghai Natural Bio-engineering Co Artemisinin Derivatives Product Portfolios and Specifications
Table 100. Shanghai Natural Bio-engineering Co Artemisinin Derivatives Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 101. Shanghai Natural Bio-engineering Co Main Business
Table 102. Shanghai Natural Bio-engineering Co Latest Developments
Table 103. Novanat Bioresource Basic Information, Artemisinin Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 104. Novanat Bioresource Artemisinin Derivatives Product Portfolios and Specifications
Table 105. Novanat Bioresource Artemisinin Derivatives Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 106. Novanat Bioresource Main Business
Table 107. Novanat Bioresource Latest Developments
Table 108. Botanical Extracts EPZ Ltd Basic Information, Artemisinin Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 109. Botanical Extracts EPZ Ltd Artemisinin Derivatives Product Portfolios and Specifications
Table 110. Botanical Extracts EPZ Ltd Artemisinin Derivatives Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 111. Botanical Extracts EPZ Ltd Main Business
Table 112. Botanical Extracts EPZ Ltd Latest Developments
LIST OFFIGURES
Figure 1. Picture of Artemisinin Derivatives
Figure 2. Artemisinin Derivatives Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Artemisinin Derivatives Sales Growth Rate 2020-2031 (MT)
Figure 7. Global Artemisinin Derivatives Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Artemisinin Derivatives Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Artemisinin Derivatives Sales Market Share by Country/Region (2024)
Figure 10. Artemisinin Derivatives Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Dihydroartemisinin
Figure 12. Product Picture of Artemisunate
Figure 13. Product Picture of Others
Figure 14. Global Artemisinin Derivatives Sales Market Share byType in 2025
Figure 15. Global Artemisinin Derivatives Revenue Market Share byType (2020-2025)
Figure 16. Artemisinin Derivatives Consumed in MalariaTreatment
Figure 17. Global Artemisinin Derivatives Market: MalariaTreatment (2020-2025) & (MT)
Figure 18. Artemisinin Derivatives Consumed in Scientific Research
Figure 19. Global Artemisinin Derivatives Market: Scientific Research (2020-2025) & (MT)
Figure 20. Artemisinin Derivatives Consumed in Others
Figure 21. Global Artemisinin Derivatives Market: Others (2020-2025) & (MT)
Figure 22. Global Artemisinin Derivatives Sale Market Share by Application (2024)
Figure 23. Global Artemisinin Derivatives Revenue Market Share by Application in 2025
Figure 24. Artemisinin Derivatives Sales by Company in 2025 (MT)
Figure 25. Global Artemisinin Derivatives Sales Market Share by Company in 2025
Figure 26. Artemisinin Derivatives Revenue by Company in 2025 ($ millions)
Figure 27. Global Artemisinin Derivatives Revenue Market Share by Company in 2025
Figure 28. Global Artemisinin Derivatives Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Artemisinin Derivatives Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Artemisinin Derivatives Sales 2020-2025 (MT)
Figure 31. Americas Artemisinin Derivatives Revenue 2020-2025 ($ millions)
Figure 32. APAC Artemisinin Derivatives Sales 2020-2025 (MT)
Figure 33. APAC Artemisinin Derivatives Revenue 2020-2025 ($ millions)
Figure 34. Europe Artemisinin Derivatives Sales 2020-2025 (MT)
Figure 35. Europe Artemisinin Derivatives Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Artemisinin Derivatives Sales 2020-2025 (MT)
Figure 37. Middle East & Africa Artemisinin Derivatives Revenue 2020-2025 ($ millions)
Figure 38. Americas Artemisinin Derivatives Sales Market Share by Country in 2025
Figure 39. Americas Artemisinin Derivatives Revenue Market Share by Country (2020-2025)
Figure 40. Americas Artemisinin Derivatives Sales Market Share byType (2020-2025)
Figure 41. Americas Artemisinin Derivatives Sales Market Share by Application (2020-2025)
Figure 42. United States Artemisinin Derivatives Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Artemisinin Derivatives Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Artemisinin Derivatives Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Artemisinin Derivatives Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Artemisinin Derivatives Sales Market Share by Region in 2025
Figure 47. APAC Artemisinin Derivatives Revenue Market Share by Region (2020-2025)
Figure 48. APAC Artemisinin Derivatives Sales Market Share byType (2020-2025)
Figure 49. APAC Artemisinin Derivatives Sales Market Share by Application (2020-2025)
Figure 50. China Artemisinin Derivatives Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Artemisinin Derivatives Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Artemisinin Derivatives Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Artemisinin Derivatives Revenue Growth 2020-2025 ($ millions)
Figure 54. India Artemisinin Derivatives Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Artemisinin Derivatives Revenue Growth 2020-2025 ($ millions)
Figure 56. ChinaTaiwan Artemisinin Derivatives Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Artemisinin Derivatives Sales Market Share by Country in 2025
Figure 58. Europe Artemisinin Derivatives Revenue Market Share by Country (2020-2025)
Figure 59. Europe Artemisinin Derivatives Sales Market Share byType (2020-2025)
Figure 60. Europe Artemisinin Derivatives Sales Market Share by Application (2020-2025)
Figure 61. Germany Artemisinin Derivatives Revenue Growth 2020-2025 ($ millions)
Figure 62.France Artemisinin Derivatives Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Artemisinin Derivatives Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Artemisinin Derivatives Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Artemisinin Derivatives Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Artemisinin Derivatives Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Artemisinin Derivatives Sales Market Share byType (2020-2025)
Figure 68. Middle East & Africa Artemisinin Derivatives Sales Market Share by Application (2020-2025)
Figure 69. Egypt Artemisinin Derivatives Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Artemisinin Derivatives Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Artemisinin Derivatives Revenue Growth 2020-2025 ($ millions)
Figure 72.Turkey Artemisinin Derivatives Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Artemisinin Derivatives Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Artemisinin Derivatives in 2025
Figure 75. Manufacturing Process Analysis of Artemisinin Derivatives
Figure 76. Industry Chain Structure of Artemisinin Derivatives
Figure 77. Channels of Distribution
Figure 78. Global Artemisinin Derivatives Sales MarketForecast by Region (2026-2031)
Figure 79. Global Artemisinin Derivatives Revenue Market ShareForecast by Region (2026-2031)
Figure 80. Global Artemisinin Derivatives Sales Market ShareForecast byType (2026-2031)
Figure 81. Global Artemisinin Derivatives Revenue Market ShareForecast byType (2026-2031)
Figure 82. Global Artemisinin Derivatives Sales Market ShareForecast by Application (2026-2031)
Figure 83. Global Artemisinin Derivatives Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Artemisinin Derivatives Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Artemisinin Derivatives by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Artemisinin Derivatives by Country/Region, 2020, 2024 & 2031
2.2 Artemisinin Derivatives Segment by Type
2.2.1 Dihydroartemisinin
2.2.2 Artemisunate
2.2.3 Others
2.3 Artemisinin Derivatives Sales by Type
2.3.1 Global Artemisinin Derivatives Sales Market Share by Type (2020-2025)
2.3.2 Global Artemisinin Derivatives Revenue and Market Share by Type (2020-2025)
2.3.3 Global Artemisinin Derivatives Sale Price by Type (2020-2025)
2.4 Artemisinin Derivatives Segment by Application
2.4.1 Malaria Treatment
2.4.2 Scientific Research
2.4.3 Others
2.5 Artemisinin Derivatives Sales by Application
2.5.1 Global Artemisinin Derivatives Sale Market Share by Application (2020-2025)
2.5.2 Global Artemisinin Derivatives Revenue and Market Share by Application (2020-2025)
2.5.3 Global Artemisinin Derivatives Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Artemisinin Derivatives Breakdown Data by Company
3.1.1 Global Artemisinin Derivatives Annual Sales by Company (2020-2025)
3.1.2 Global Artemisinin Derivatives Sales Market Share by Company (2020-2025)
3.2 Global Artemisinin Derivatives Annual Revenue by Company (2020-2025)
3.2.1 Global Artemisinin Derivatives Revenue by Company (2020-2025)
3.2.2 Global Artemisinin Derivatives Revenue Market Share by Company (2020-2025)
3.3 Global Artemisinin Derivatives Sale Price by Company
3.4 Key Manufacturers Artemisinin Derivatives Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Artemisinin Derivatives Product Location Distribution
3.4.2 Players Artemisinin Derivatives Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ARTEMISININ DERIVATIVES BY GEOGRAPHIC REGION
4.1 World Historic Artemisinin Derivatives Market Size by Geographic Region (2020-2025)
4.1.1 Global Artemisinin Derivatives Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Artemisinin Derivatives Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Artemisinin Derivatives Market Size by Country/Region (2020-2025)
4.2.1 Global Artemisinin Derivatives Annual Sales by Country/Region (2020-2025)
4.2.2 Global Artemisinin Derivatives Annual Revenue by Country/Region (2020-2025)
4.3 Americas Artemisinin Derivatives Sales Growth
4.4 APAC Artemisinin Derivatives Sales Growth
4.5 Europe Artemisinin Derivatives Sales Growth
4.6 Middle East & Africa Artemisinin Derivatives Sales Growth
5 AMERICAS
5.1 Americas Artemisinin Derivatives Sales by Country
5.1.1 Americas Artemisinin Derivatives Sales by Country (2020-2025)
5.1.2 Americas Artemisinin Derivatives Revenue by Country (2020-2025)
5.2 Americas Artemisinin Derivatives Sales by Type (2020-2025)
5.3 Americas Artemisinin Derivatives Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artemisinin Derivatives Sales by Region
6.1.1 APAC Artemisinin Derivatives Sales by Region (2020-2025)
6.1.2 APAC Artemisinin Derivatives Revenue by Region (2020-2025)
6.2 APAC Artemisinin Derivatives Sales by Type (2020-2025)
6.3 APAC Artemisinin Derivatives Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Artemisinin Derivatives by Country
7.1.1 Europe Artemisinin Derivatives Sales by Country (2020-2025)
7.1.2 Europe Artemisinin Derivatives Revenue by Country (2020-2025)
7.2 Europe Artemisinin Derivatives Sales by Type (2020-2025)
7.3 Europe Artemisinin Derivatives Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Artemisinin Derivatives by Country
8.1.1 Middle East & Africa Artemisinin Derivatives Sales by Country (2020-2025)
8.1.2 Middle East & Africa Artemisinin Derivatives Revenue by Country (2020-2025)
8.2 Middle East & Africa Artemisinin Derivatives Sales by Type (2020-2025)
8.3 Middle East & Africa Artemisinin Derivatives Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Artemisinin Derivatives
10.3 Manufacturing Process Analysis of Artemisinin Derivatives
10.4 Industry Chain Structure of Artemisinin Derivatives
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Artemisinin Derivatives Distributors
11.3 Artemisinin Derivatives Customer
12 WORLD FORECAST REVIEW FOR ARTEMISININ DERIVATIVES BY GEOGRAPHIC REGION
12.1 Global Artemisinin Derivatives Market Size Forecast by Region
12.1.1 Global Artemisinin Derivatives Forecast by Region (2026-2031)
12.1.2 Global Artemisinin Derivatives Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Artemisinin Derivatives Forecast by Type (2026-2031)
12.7 Global Artemisinin Derivatives Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Artemisinin Derivatives Product Portfolios and Specifications
13.1.3 Sanofi Artemisinin Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 KPC Pharmaceuticals
13.2.1 KPC Pharmaceuticals Company Information
13.2.2 KPC Pharmaceuticals Artemisinin Derivatives Product Portfolios and Specifications
13.2.3 KPC Pharmaceuticals Artemisinin Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 KPC Pharmaceuticals Main Business Overview
13.2.5 KPC Pharmaceuticals Latest Developments
13.3 Guangxi Xiancaotang Pharmaceutical
13.3.1 Guangxi Xiancaotang Pharmaceutical Company Information
13.3.2 Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Product Portfolios and Specifications
13.3.3 Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Guangxi Xiancaotang Pharmaceutical Main Business Overview
13.3.5 Guangxi Xiancaotang Pharmaceutical Latest Developments
13.4 Guilin Pharmaceutical
13.4.1 Guilin Pharmaceutical Company Information
13.4.2 Guilin Pharmaceutical Artemisinin Derivatives Product Portfolios and Specifications
13.4.3 Guilin Pharmaceutical Artemisinin Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Guilin Pharmaceutical Main Business Overview
13.4.5 Guilin Pharmaceutical Latest Developments
13.5 Kerui Nanhai Pharmaceutical
13.5.1 Kerui Nanhai Pharmaceutical Company Information
13.5.2 Kerui Nanhai Pharmaceutical Artemisinin Derivatives Product Portfolios and Specifications
13.5.3 Kerui Nanhai Pharmaceutical Artemisinin Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Kerui Nanhai Pharmaceutical Main Business Overview
13.5.5 Kerui Nanhai Pharmaceutical Latest Developments
13.6 Shanghai Natural Bio-engineering Co
13.6.1 Shanghai Natural Bio-engineering Co Company Information
13.6.2 Shanghai Natural Bio-engineering Co Artemisinin Derivatives Product Portfolios and Specifications
13.6.3 Shanghai Natural Bio-engineering Co Artemisinin Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Shanghai Natural Bio-engineering Co Main Business Overview
13.6.5 Shanghai Natural Bio-engineering Co Latest Developments
13.7 Novanat Bioresource
13.7.1 Novanat Bioresource Company Information
13.7.2 Novanat Bioresource Artemisinin Derivatives Product Portfolios and Specifications
13.7.3 Novanat Bioresource Artemisinin Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Novanat Bioresource Main Business Overview
13.7.5 Novanat Bioresource Latest Developments
13.8 Botanical Extracts EPZ Ltd
13.8.1 Botanical Extracts EPZ Ltd Company Information
13.8.2 Botanical Extracts EPZ Ltd Artemisinin Derivatives Product Portfolios and Specifications
13.8.3 Botanical Extracts EPZ Ltd Artemisinin Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Botanical Extracts EPZ Ltd Main Business Overview
13.8.5 Botanical Extracts EPZ Ltd Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Artemisinin Derivatives Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Artemisinin Derivatives Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Dihydroartemisinin
Table 4. Major Players of Artemisunate
Table 5. Major Players of Others
Table 6. Global Artemisinin Derivatives Sales byType (2020-2025) & (MT)
Table 7. Global Artemisinin Derivatives Sales Market Share byType (2020-2025)
Table 8. Global Artemisinin Derivatives Revenue byType (2020-2025) & ($ million)
Table 9. Global Artemisinin Derivatives Revenue Market Share byType (2020-2025)
Table 10. Global Artemisinin Derivatives Sale Price byType (2020-2025) & (USD/MT)
Table 11. Global Artemisinin Derivatives Sale by Application (2020-2025) & (MT)
Table 12. Global Artemisinin Derivatives Sale Market Share by Application (2020-2025)
Table 13. Global Artemisinin Derivatives Revenue by Application (2020-2025) & ($ million)
Table 14. Global Artemisinin Derivatives Revenue Market Share by Application (2020-2025)
Table 15. Global Artemisinin Derivatives Sale Price by Application (2020-2025) & (USD/MT)
Table 16. Global Artemisinin Derivatives Sales by Company (2020-2025) & (MT)
Table 17. Global Artemisinin Derivatives Sales Market Share by Company (2020-2025)
Table 18. Global Artemisinin Derivatives Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Artemisinin Derivatives Revenue Market Share by Company (2020-2025)
Table 20. Global Artemisinin Derivatives Sale Price by Company (2020-2025) & (USD/MT)
Table 21. Key Manufacturers Artemisinin Derivatives Producing Area Distribution and Sales Area
Table 22. Players Artemisinin Derivatives Products Offered
Table 23. Artemisinin Derivatives Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Artemisinin Derivatives Sales by Geographic Region (2020-2025) & (MT)
Table 27. Global Artemisinin Derivatives Sales Market Share Geographic Region (2020-2025)
Table 28. Global Artemisinin Derivatives Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Artemisinin Derivatives Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Artemisinin Derivatives Sales by Country/Region (2020-2025) & (MT)
Table 31. Global Artemisinin Derivatives Sales Market Share by Country/Region (2020-2025)
Table 32. Global Artemisinin Derivatives Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Artemisinin Derivatives Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Artemisinin Derivatives Sales by Country (2020-2025) & (MT)
Table 35. Americas Artemisinin Derivatives Sales Market Share by Country (2020-2025)
Table 36. Americas Artemisinin Derivatives Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Artemisinin Derivatives Sales byType (2020-2025) & (MT)
Table 38. Americas Artemisinin Derivatives Sales by Application (2020-2025) & (MT)
Table 39. APAC Artemisinin Derivatives Sales by Region (2020-2025) & (MT)
Table 40. APAC Artemisinin Derivatives Sales Market Share by Region (2020-2025)
Table 41. APAC Artemisinin Derivatives Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Artemisinin Derivatives Sales byType (2020-2025) & (MT)
Table 43. APAC Artemisinin Derivatives Sales by Application (2020-2025) & (MT)
Table 44. Europe Artemisinin Derivatives Sales by Country (2020-2025) & (MT)
Table 45. Europe Artemisinin Derivatives Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Artemisinin Derivatives Sales byType (2020-2025) & (MT)
Table 47. Europe Artemisinin Derivatives Sales by Application (2020-2025) & (MT)
Table 48. Middle East & Africa Artemisinin Derivatives Sales by Country (2020-2025) & (MT)
Table 49. Middle East & Africa Artemisinin Derivatives Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Artemisinin Derivatives Sales byType (2020-2025) & (MT)
Table 51. Middle East & Africa Artemisinin Derivatives Sales by Application (2020-2025) & (MT)
Table 52. Key Market Drivers & Growth Opportunities of Artemisinin Derivatives
Table 53. Key Market Challenges & Risks of Artemisinin Derivatives
Table 54. Key IndustryTrends of Artemisinin Derivatives
Table 55. Artemisinin Derivatives Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Artemisinin Derivatives Distributors List
Table 58. Artemisinin Derivatives Customer List
Table 59. Global Artemisinin Derivatives SalesForecast by Region (2026-2031) & (MT)
Table 60. Global Artemisinin Derivatives RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Artemisinin Derivatives SalesForecast by Country (2026-2031) & (MT)
Table 62. Americas Artemisinin Derivatives Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Artemisinin Derivatives SalesForecast by Region (2026-2031) & (MT)
Table 64. APAC Artemisinin Derivatives Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Artemisinin Derivatives SalesForecast by Country (2026-2031) & (MT)
Table 66. Europe Artemisinin Derivatives RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Artemisinin Derivatives SalesForecast by Country (2026-2031) & (MT)
Table 68. Middle East & Africa Artemisinin Derivatives RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Artemisinin Derivatives SalesForecast byType (2026-2031) & (MT)
Table 70. Global Artemisinin Derivatives RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Artemisinin Derivatives SalesForecast by Application (2026-2031) & (MT)
Table 72. Global Artemisinin Derivatives RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Sanofi Basic Information, Artemisinin Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 74. Sanofi Artemisinin Derivatives Product Portfolios and Specifications
Table 75. Sanofi Artemisinin Derivatives Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 76. Sanofi Main Business
Table 77. Sanofi Latest Developments
Table 78. KPC Pharmaceuticals Basic Information, Artemisinin Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 79. KPC Pharmaceuticals Artemisinin Derivatives Product Portfolios and Specifications
Table 80. KPC Pharmaceuticals Artemisinin Derivatives Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 81. KPC Pharmaceuticals Main Business
Table 82. KPC Pharmaceuticals Latest Developments
Table 83. Guangxi Xiancaotang Pharmaceutical Basic Information, Artemisinin Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 84. Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Product Portfolios and Specifications
Table 85. Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Guangxi Xiancaotang Pharmaceutical Main Business
Table 87. Guangxi Xiancaotang Pharmaceutical Latest Developments
Table 88. Guilin Pharmaceutical Basic Information, Artemisinin Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 89. Guilin Pharmaceutical Artemisinin Derivatives Product Portfolios and Specifications
Table 90. Guilin Pharmaceutical Artemisinin Derivatives Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 91. Guilin Pharmaceutical Main Business
Table 92. Guilin Pharmaceutical Latest Developments
Table 93. Kerui Nanhai Pharmaceutical Basic Information, Artemisinin Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 94. Kerui Nanhai Pharmaceutical Artemisinin Derivatives Product Portfolios and Specifications
Table 95. Kerui Nanhai Pharmaceutical Artemisinin Derivatives Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 96. Kerui Nanhai Pharmaceutical Main Business
Table 97. Kerui Nanhai Pharmaceutical Latest Developments
Table 98. Shanghai Natural Bio-engineering Co Basic Information, Artemisinin Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 99. Shanghai Natural Bio-engineering Co Artemisinin Derivatives Product Portfolios and Specifications
Table 100. Shanghai Natural Bio-engineering Co Artemisinin Derivatives Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 101. Shanghai Natural Bio-engineering Co Main Business
Table 102. Shanghai Natural Bio-engineering Co Latest Developments
Table 103. Novanat Bioresource Basic Information, Artemisinin Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 104. Novanat Bioresource Artemisinin Derivatives Product Portfolios and Specifications
Table 105. Novanat Bioresource Artemisinin Derivatives Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 106. Novanat Bioresource Main Business
Table 107. Novanat Bioresource Latest Developments
Table 108. Botanical Extracts EPZ Ltd Basic Information, Artemisinin Derivatives Manufacturing Base, Sales Area and Its Competitors
Table 109. Botanical Extracts EPZ Ltd Artemisinin Derivatives Product Portfolios and Specifications
Table 110. Botanical Extracts EPZ Ltd Artemisinin Derivatives Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 111. Botanical Extracts EPZ Ltd Main Business
Table 112. Botanical Extracts EPZ Ltd Latest Developments
LIST OFFIGURES
Figure 1. Picture of Artemisinin Derivatives
Figure 2. Artemisinin Derivatives Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Artemisinin Derivatives Sales Growth Rate 2020-2031 (MT)
Figure 7. Global Artemisinin Derivatives Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Artemisinin Derivatives Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Artemisinin Derivatives Sales Market Share by Country/Region (2024)
Figure 10. Artemisinin Derivatives Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Dihydroartemisinin
Figure 12. Product Picture of Artemisunate
Figure 13. Product Picture of Others
Figure 14. Global Artemisinin Derivatives Sales Market Share byType in 2025
Figure 15. Global Artemisinin Derivatives Revenue Market Share byType (2020-2025)
Figure 16. Artemisinin Derivatives Consumed in MalariaTreatment
Figure 17. Global Artemisinin Derivatives Market: MalariaTreatment (2020-2025) & (MT)
Figure 18. Artemisinin Derivatives Consumed in Scientific Research
Figure 19. Global Artemisinin Derivatives Market: Scientific Research (2020-2025) & (MT)
Figure 20. Artemisinin Derivatives Consumed in Others
Figure 21. Global Artemisinin Derivatives Market: Others (2020-2025) & (MT)
Figure 22. Global Artemisinin Derivatives Sale Market Share by Application (2024)
Figure 23. Global Artemisinin Derivatives Revenue Market Share by Application in 2025
Figure 24. Artemisinin Derivatives Sales by Company in 2025 (MT)
Figure 25. Global Artemisinin Derivatives Sales Market Share by Company in 2025
Figure 26. Artemisinin Derivatives Revenue by Company in 2025 ($ millions)
Figure 27. Global Artemisinin Derivatives Revenue Market Share by Company in 2025
Figure 28. Global Artemisinin Derivatives Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Artemisinin Derivatives Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Artemisinin Derivatives Sales 2020-2025 (MT)
Figure 31. Americas Artemisinin Derivatives Revenue 2020-2025 ($ millions)
Figure 32. APAC Artemisinin Derivatives Sales 2020-2025 (MT)
Figure 33. APAC Artemisinin Derivatives Revenue 2020-2025 ($ millions)
Figure 34. Europe Artemisinin Derivatives Sales 2020-2025 (MT)
Figure 35. Europe Artemisinin Derivatives Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Artemisinin Derivatives Sales 2020-2025 (MT)
Figure 37. Middle East & Africa Artemisinin Derivatives Revenue 2020-2025 ($ millions)
Figure 38. Americas Artemisinin Derivatives Sales Market Share by Country in 2025
Figure 39. Americas Artemisinin Derivatives Revenue Market Share by Country (2020-2025)
Figure 40. Americas Artemisinin Derivatives Sales Market Share byType (2020-2025)
Figure 41. Americas Artemisinin Derivatives Sales Market Share by Application (2020-2025)
Figure 42. United States Artemisinin Derivatives Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Artemisinin Derivatives Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Artemisinin Derivatives Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Artemisinin Derivatives Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Artemisinin Derivatives Sales Market Share by Region in 2025
Figure 47. APAC Artemisinin Derivatives Revenue Market Share by Region (2020-2025)
Figure 48. APAC Artemisinin Derivatives Sales Market Share byType (2020-2025)
Figure 49. APAC Artemisinin Derivatives Sales Market Share by Application (2020-2025)
Figure 50. China Artemisinin Derivatives Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Artemisinin Derivatives Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Artemisinin Derivatives Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Artemisinin Derivatives Revenue Growth 2020-2025 ($ millions)
Figure 54. India Artemisinin Derivatives Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Artemisinin Derivatives Revenue Growth 2020-2025 ($ millions)
Figure 56. ChinaTaiwan Artemisinin Derivatives Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Artemisinin Derivatives Sales Market Share by Country in 2025
Figure 58. Europe Artemisinin Derivatives Revenue Market Share by Country (2020-2025)
Figure 59. Europe Artemisinin Derivatives Sales Market Share byType (2020-2025)
Figure 60. Europe Artemisinin Derivatives Sales Market Share by Application (2020-2025)
Figure 61. Germany Artemisinin Derivatives Revenue Growth 2020-2025 ($ millions)
Figure 62.France Artemisinin Derivatives Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Artemisinin Derivatives Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Artemisinin Derivatives Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Artemisinin Derivatives Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Artemisinin Derivatives Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Artemisinin Derivatives Sales Market Share byType (2020-2025)
Figure 68. Middle East & Africa Artemisinin Derivatives Sales Market Share by Application (2020-2025)
Figure 69. Egypt Artemisinin Derivatives Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Artemisinin Derivatives Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Artemisinin Derivatives Revenue Growth 2020-2025 ($ millions)
Figure 72.Turkey Artemisinin Derivatives Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Artemisinin Derivatives Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Artemisinin Derivatives in 2025
Figure 75. Manufacturing Process Analysis of Artemisinin Derivatives
Figure 76. Industry Chain Structure of Artemisinin Derivatives
Figure 77. Channels of Distribution
Figure 78. Global Artemisinin Derivatives Sales MarketForecast by Region (2026-2031)
Figure 79. Global Artemisinin Derivatives Revenue Market ShareForecast by Region (2026-2031)
Figure 80. Global Artemisinin Derivatives Sales Market ShareForecast byType (2026-2031)
Figure 81. Global Artemisinin Derivatives Revenue Market ShareForecast byType (2026-2031)
Figure 82. Global Artemisinin Derivatives Sales Market ShareForecast by Application (2026-2031)
Figure 83. Global Artemisinin Derivatives Revenue Market ShareForecast by Application (2026-2031)
